Samrat Pharmachem Ltd
₹0.00▲ +0.00 (+0.00%)
530125·NSE·Healthcare
Market Cap
76.03 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
375.45 - 190.00
₹0.00▲ +0.00 (+0.00%)
Market Cap76.03 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low375.45 - 190.00
Samrat Pharmachem Ltd (530125): company summary
Samrat Pharmachem Ltd (530125) is a micro-cap Healthcare company valued at ₹76 crore operating in Pharmaceuticals on the NSE and BSE.
Samrat Pharmachem Ltd (530125) is a micro-cap Healthcare company valued at ₹76 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -2.3% a year over three years. Return on equity is -4.7%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 1.12 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
3.7/10
Poor
Fair Value
Sign in to see
ROE
-4.73%
Weak
P/E
—
Debt / Equity
0.16
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹190.00
₹375.45
DocStoX take
Supported by valuation (6.0), but held back by quality (2.1). Scored on 4 of 5 measures.
DocStoX score
Medium confidence3.7
/10
Poor
Quality
Weak
ROE -4.7%
Valuation
Fair
P/B 1.1× on assets (no earnings to value)
Growth
Slow
Revenue +10.1% 5Y CAGR
Risk
Elevated
D/E 0.16
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹76 Cr
52W High / Low
₹375 / ₹190
Dividend Yield
0.41%
Promoter Holding
49.09%
EPS (TTM)
₹23.01
Book Value
₹220.67
Key highlights
- Low leverage — D/E 0.16
- Quality is weak (2.1/10)
- Small ₹76 cr company — thinner liquidity
1 Positive2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Samrat Pharmachem Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Samrat Pharmachem Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Samrat Pharmachem Ltd with peers
Related tools & concepts
Value Samrat Pharmachem Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing